SCHEMBL29160481

SCHEMBL29160481

Cc1c(N2CCOCC2)oc2ccc(C(=O)O)cc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 6/20 0.48
P2RY12 Q9H244 1/20 0.46
KMO O15229 1/20 0.45
AKR1B1 P15121 1/20 0.44
TBK1 Q9UHD2 1/20 0.43
PRKDC P78527 2/20 0.43
PIK3CA P42336 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TP53 P04637 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
PTGER1 P34995 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43
PTGDR Q13258 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KCNA3 P22001 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28095892 0.89 P2RY12 (0.45) P2RY12TBK1PRKDCPIK3CAMEN1
SCHEMBL29160479 0.85 TTR (0.48) TTRKMOAKR1B1TBK1PRKDC
SCHEMBL31035311 0.83 PRKDC (0.61) P2RY12PRKDCKMT2AKDM4EALDH1A1
SCHEMBL29160429 0.76 PRKDC (0.65) PRKDCPIK3CAKDM4EALDH1A1TP53
SCHEMBL7315291 0.76 PRKDC (0.59) P2RY12AKR1B1PRKDCMEN1KMT2A
SCHEMBL30768013 0.76 PIK3CB (0.48) PIK3CA
SCHEMBL30768016 0.72 PIK3CB (0.43) PIK3CAHSD17B10
SCHEMBL68189 0.72 TTR (0.83) TTRAKR1B1TBK1MEN1KMT2A
SCHEMBL11439145 0.72 TTR (0.59) TTRAKR1B1MEN1KMT2AKDM4E
SCHEMBL28095893 0.72 P2RY12 (0.44) P2RY12TBK1PRKDCMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117615763-A Phosphoinositide 3 kinase beta inhibitor, composition and preparation method thereof 健道生物医药有限公司 2024-02-27 CN disclosed